3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Pheochromocytoma
2
Paraganglioma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Interventions
Nivolumab
3
Cisplatin
3
atezolizumab
2
Irinotecan
2
Ipilimumab
2
Etoposide
2
Carboplatin
2
tivozanib
1
repotrectinib
1
niraparib
1
gallium Ga 68 dotatate
1
dostarlimab
1
cabozantinib
1
budigalimab
1
belinostat
1
Topotecan
1
Temozolomide
1
Specimen Handling
1
Radiosurgery
1
Radionuclide Imaging
1
Positron-Emission Tomography
1
Positron Emission Tomography Computed Tomography
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Immunoglobulin G
1
IFL protocol
1
Fluorouracil
1
Disulfides
1
DLL3 protein, human
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Neuroendocrine
×
Fluorodeoxyglucose F18
×
90 days
×
Clear all
No trials found.